Sergei Astakhov

624 total citations
6 papers, 110 citations indexed

About

Sergei Astakhov is a scholar working on Ophthalmology, Molecular Biology and Immunology. According to data from OpenAlex, Sergei Astakhov has authored 6 papers receiving a total of 110 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Ophthalmology, 2 papers in Molecular Biology and 2 papers in Immunology. Recurrent topics in Sergei Astakhov's work include Retinal Diseases and Treatments (4 papers), Retinal and Optic Conditions (3 papers) and Glaucoma and retinal disorders (3 papers). Sergei Astakhov is often cited by papers focused on Retinal Diseases and Treatments (4 papers), Retinal and Optic Conditions (3 papers) and Glaucoma and retinal disorders (3 papers). Sergei Astakhov collaborates with scholars based in Russia, United States and Croatia. Sergei Astakhov's co-authors include Denis Gubin, В. В. Нероев, Germaine Cornélissen, С. Н. Коломейчук, Dietmar Weinert, Se Joon Woo, Adrienne Csutak, Edward Wylęgała, Min Sagong and Jan Studnička and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Pineal Research and JAMA Ophthalmology.

In The Last Decade

Sergei Astakhov

6 papers receiving 108 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergei Astakhov Russia	6	62	46	31	23	20	6	110
B. Beleslin Serbia	6	6 0.1×	8 0.2×	8 0.3×	5 0.2×	26 1.3×	15	102
Mattias Andréasson Sweden	8	24 0.4×		19 0.6×	32 1.4×	15 0.8×	13	110
Lara Phillips United States	5	9 0.1×	17 0.4×	2 0.1×	10 0.4×	5 0.3×	9	66
Zijing Wang China	6	9 0.1×	4 0.1×	5 0.2×	3 0.1×	11 0.6×	13	104
Kimberly Robeson United States	5	13 0.2×	4 0.1×	11 0.4×	1 0.0×	7 0.3×	7	156
Radka Kremlíková Pourová Czechia	8	5 0.1×	11 0.2×	5 0.2×	4 0.2×	50 2.5×	18	168
E Richardson United States	1	43 0.7×	2 0.0×	37 1.2×		30 1.5×	2	90
Jia Jia Lek Australia	9	188 3.0×	1 0.0×	123 4.0×	7 0.3×	44 2.2×	15	219
Ivy Trinh United States	6		21 0.5×	7 0.2×	7 0.3×	44 2.2×	6	184

Countries citing papers authored by Sergei Astakhov

Since Specialization

Citations

This map shows the geographic impact of Sergei Astakhov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergei Astakhov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergei Astakhov more than expected).

Fields of papers citing papers by Sergei Astakhov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergei Astakhov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergei Astakhov. The network helps show where Sergei Astakhov may publish in the future.

Co-authorship network of co-authors of Sergei Astakhov

This figure shows the co-authorship network connecting the top 25 collaborators of Sergei Astakhov. A scholar is included among the top collaborators of Sergei Astakhov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergei Astakhov. Sergei Astakhov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Woo, Se Joon, Attila Vajas, Min Sagong, et al.. (2023). Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration. JAMA Ophthalmology. 141(7). 668–668. 20 indexed citations

2.

Sadda, Srinivas R., Attila Vajas, Min Sagong, et al.. (2023). Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trial. BMJ Open Ophthalmology. 8(1). e001561–e001561. 9 indexed citations

3.

Gubin, Denis, В. В. Нероев, Germaine Cornélissen, et al.. (2021). Melatonin mitigates disrupted circadian rhythms, lowers intraocular pressure, and improves retinal ganglion cells function in glaucoma. Journal of Pineal Research. 70(4). e12730–e12730. 50 indexed citations

4.

Нероев, В. В., Dietmar Weinert, Sergei Astakhov, et al.. (2020). Disruption of 24-Hour Rhythm in Intraocular Pressure Correlates with Retinal Ganglion Cell Loss in Glaucoma. International Journal of Molecular Sciences. 22(1). 359–359. 14 indexed citations

5.

Astakhov, Yury S., et al.. (2017). Alternative ways to optimize treatment for retinal vein occlusion with peripheral capillary non-perfusion: a pilot study. Arquivos Brasileiros de Oftalmologia. 80(4). 224–228. 5 indexed citations

6.

Astakhov, Sergei, et al.. (2013). Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK. Clinical ophthalmology. 7. 2289–2289. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact